GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
4 hedge funds and large institutions have $703K invested in VanEck Vectors Generic Drugs ETF in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$558K |
Top Sellers
| 1 |
NFG
Next Financial Group
Houston,
Texas
|
-$6K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $558K | +$558K | +24,687 | New |
|
2
UBS Group
Zurich,
Switzerland
| $68K | – | – | – |
|
|
IA
3
IFP Advisors
Tampa,
Florida
| $51K | – | – | – |
|
|
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $25.7K | +$25.7K | +1,141 | New |
|
|
NFG
5
Next Financial Group
Houston,
Texas
| – | -$6K | -300 | Closed |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$4K | -200 | Closed |
|